Zobrazeno 1 - 7
of 7
pro vyhledávání: '"G. V. Tochilnikov"'
Publikováno v:
Сибирский онкологический журнал, Vol 22, Iss 3, Pp 76-82 (2023)
Background. Current treatment of HER2-positive metastatic breast cancer (BC) is based on the use of anti-HER2 blockers as pathogenic drugs, as well as the search for the optimal combination of anticancer drugs with different mechanisms of action. The
Externí odkaz:
https://doaj.org/article/1933fe51bb01428a8d52283a82ab1e91
Autor:
Yu. G. Zmitrichenko, A. N. Stukov, V. А. Aleksandrov, G. V. Tochilnikov, I. G. Murazov, D. Н. Latipova, L. V. Filatova, T. Yu. Semiglazova
Publikováno v:
Фармакокинетика и Фармакодинамика, Vol 0, Iss 3, Pp 26-32 (2022)
Background. Alkylating drugs have been used in tumor chemo therapy for many decades, and the search for effective compounds continues.The aim of the study was to study the activity of the developed new compound – 2-[3-(2-chloroethyl)-3-nitrosoureid
Externí odkaz:
https://doaj.org/article/927a039666544620aa7d17ba11e70d64
Autor:
I. G. Murazov, A. N. Stukov, Iu. G. Zmitrichenko, A. O. Niuganen, G. V. Tochilnikov, D. Ch. Latipova, L. V. Filatova, T. Yu. Semiglazova
Publikováno v:
Фармакокинетика и Фармакодинамика, Vol 0, Iss 1, Pp 23-29 (2021)
Background. The arsenal of antitumor drug therapy for melanoma brain metastases is limited. The search and study of new agents capable to penetrate the blood-brain barrier and provide a therapeutic effect against intracranial tumors remains an unmet
Externí odkaz:
https://doaj.org/article/e4a9a9556bb547738722f3008d86e664
Autor:
A. N. Stukov, S. F. Vershinina, N. A. Koziavin, T. Yu. Semiglazova, L. V. Filatova, D. Kh. Latipova, A. O. Ivantsov, V. G. Bespalov, A. L. Semenov, O. A. Belyaeva, G. S. Kireeva, V. A. Alexandrov, G. V. Tochilnikov, I. N. Vasilyeva, M. A. Maydin, M. L. Tyndyk, S. S. Kruglov, G. A. Yanus, V. N. Yurova
Publikováno v:
Сибирский онкологический журнал, Vol 18, Iss 5, Pp 54-60 (2019)
Because of the high risk of brain metastases from HER2-positive breast cancer, the study of the anticancer activity of drugs used to treat brain tumors, in particular lomustine, is of great importance. In the FVB/N Her-2 transgenic mice bearing HER2-
Externí odkaz:
https://doaj.org/article/d4de6c83be42427f8b4c74e1808c76a0
Autor:
I. N. Vasilyeva, V. G. Bespalov, J. D. Von, A. L. Semenov, G. V. Tochilnikov, V. A. Romanov, I. K. Alvovsky, D. A. Baranenko
Publikováno v:
International Journal of Genomics, Vol 2019 (2019)
The purpose of this work was to study changes in the level of cell-free DNA (cfDNA) in the blood of young and old rats in the normal state and with induced benign prostatic hyperplasia (BPH). Male Wistar rats were divided into 4 groups—young (3 mon
Externí odkaz:
https://doaj.org/article/fd26177e52b949a3938588385bf4f2b7
Publikováno v:
Pharmaceutical Chemistry Journal. 56:1179-1182
Autor:
A. L. Semenov, E. D. Ermakova, Yu. G. Zmitrichenko, G. V. Tochilnikov, D. E. Lukin, V. A. Alexandrov
Publikováno v:
AIP Conference Proceedings.